• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

mallinckrodt

  1. Open Letter from Mallinckrodt Investor Reporting Fraud Reported to U.S. Securities and Exchange Comm

    "Accounting Fraud, Bankruptcy Fraud, Insider Trading, Proxy Fraud, and Electoral Fraud - Mallinckrodt Plc." October 22, 2021, open letter to the U.S. Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/1567892/000106299321009816/exhibit99-2.htm October 22, 2021, open...
  2. Hospital Leadership

    So let me get this straight - the only division that is really doing well is hospital and the current hospital leadership that has delivered these results year after year is NOT being rewarded with the ability to continue leading their team? And furthermore we are handing the reigns to a person...
  3. Retention Bonus

    Congrats everyone! Looks like we are getting retention bonus! Stock market reported mnk giving out 4M in retention bonuses! Good that we stayed. Has anyone been given the document to sign yet?
  4. Acthar Ambassador Program???

    Does anyone have any details about the Acthar Ambassador Program??? How much is MNK paying patients involved, how big is it, and why is MNK trying to hide it? https://actharambassador.com/
  5. Mallinckrodt co-pay charities

    Does anyone have any idea which charities MNK uses to funnel co-pay assistance money?